CPC Subgroup
C12Y 107/01 with NAD+ or NADP+ as acceptor (1.7.1)
Full Title
Oxidoreductases acting on other nitrogenous compounds as donors (1.7) > with NAD+ or NADP+ as acceptor (1.7.1)
13 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 107/01001 Nitrate reductase (NADH) (1.7.1.1)
- C12Y 107/01002 Nitrate reductase [NAD(P)H] (1.7.1.2)
- C12Y 107/01003 Nitrate reductase (NADPH) (1.7.1.3)
- C12Y 107/01004 Nitrite reductase [NAD(P)H] (1.7.1.4)
- C12Y 107/01005 Hyponitrite reductase (1.7.1.5)
- C12Y 107/01006 Azobenzene reductase (1.7.1.6)
- C12Y 107/01007 GMP reductase (1.7.1.7)
- C12Y 107/01009 Nitroquinoline-N-oxide reductase (1.7.1.9)
- C12Y 107/0101 Hydroxylamine reductase (NADH) (1.7.1.10)
- C12Y 107/01011 4-(Dimethylamino)phenylazoxybenzene reductase (1.7.1.11)
- C12Y 107/01012 N-Hydroxy-2-acetamidofluorene reductase (1.7.1.12)
- C12Y 107/01013 PreQ1 synthase (1.7.1.13)
- C12Y 107/01014 Nitric oxide reductase (NAD(P), nitrous oxide-forming)(1.7.1.14)
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692